Circulation. 2001;104:2716-2721
doi: 10.1161/hc4601.099404
doi: 10.1161/hc4601.099404
(Circulation. 2001;104:2716.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury
From the Department of Medical Biochemistry, Ehime University School of Medicine, Ehime (L.W., M.I., H.N., Z.L., R.C., J.S., M.H.), and the Department of Geriatric Medicine, Kyorin University School of Medicine, Tokyo (M.A.), Japan; and Novartis Pharma AG, Basel, Switzerland (M.d.G.).
Correspondence to Masatsugu Horiuchi, MD, PhD, Department of Medical Biochemistry, Ehime University School of Medicine, Shigenobu, Onsen-gun, Ehime 791-0295, Japan. E-mail horiuchi{at}m.ehime-u.ac.jp
Background— To investigate the effect of angiotensin (Ang) II type 1 receptor (AT1) blocker on vascular remodeling and explore the possibility of the involvement of Ang II type 2 receptor (AT2) stimulation in this process, we examined the effects of the selective AT1 blocker valsartan on the vascular injury in wild-type (Agtr2+) and AT2-null (Agtr2-) mice.
Methods and Results— Neointima formation and the proliferation of vascular smooth muscle cells (VSMCs) induced by cuff placement on the femoral artery were greater in Agtr2- mice than those in Agtr2+ mice. Treatment of mice with valsartan at a dose of 1 mg · kg-1 · d-1, which did not influence systolic blood pressure, significantly decreased neointima formation and the proliferation of VSMCs, whereas the valsartan was less effective in Agtr2- mice. Moreover, cuff placement increased the expression of monocyte chemoattractant protein-1 (MCP-1); inflammatory cytokines such as tumor necrosis factor (TNF)-
, interleukin (IL)-6, and IL-1ß; and infiltration of CD45-positive leukocytes and macrophages in the injured arteries and further enhanced them in Agtr2- mice, suggesting the antagonistic effects of AT1 and AT2 for vascular inflammation. Valsartan attenuated the expression of MCP-1, TNF-, IL-6, IL-1ß, and infiltration of leukocytes and macrophages in the injured arteries; however, these effects of valsartan were less prominent in Agtr2- mice.
Conclusions— These results suggest that the stimulation of the AT2 receptor after AT1 blockade is important in the improvement of the inflammatory vascular injury.
Key Words: angiotensin • arteries • inflammation • receptors • remodeling
This article has been cited by other articles:
 |
|
 |
|
  T. Fujita, M. Mogi, L.-J. Min, J. Iwanami, K. Tsukuda, A. Sakata, H. Okayama, M. Iwai, C. Nahmias, J. Higaki, et al. Attenuation of Cuff-Induced Neointimal Formation by Overexpression of Angiotensin II Type 2 Receptor-Interacting Protein 1 Hypertension, April 1, 2009; 53(4): 688 - 693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Ulmasov, Z. Xu, L. H. Tetri, T. Inagami, and B. A. Neuschwander-Tetri Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G284 - G294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Talelli and R. J. Greenwood Review: Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 387 - 405. [Abstract] [PDF]
|
|
|
|
 |
|
 R. C Parish and J. D Evans Inflammation in Chronic Heart Failure Ann. Pharmacother., July 1, 2008; 42(7): 1002 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Brooke, J. P. Habashi, D. P. Judge, N. Patel, B. Loeys, and H. C. Dietz III Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome N. Engl. J. Med., June 26, 2008; 358(26): 2787 - 2795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sriramula, M. Haque, D. S.A. Majid, and J. Francis Involvement of Tumor Necrosis Factor-{alpha} in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy Hypertension, May 1, 2008; 51(5): 1345 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, Y. Doerffel, B. Hocher, and T. Unger Inflammation in the genesis of hypertension and its complications the role of angiotensin II Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3107 - 3109. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mateo, Y. Naim Abu Nabah, M. Losada, R. Estelles, C. Company, B. Bedrina, J. M. Cerda-Nicolas, S. Poole, P. J. Jose, J. Cortijo, et al. A critical role for TNF{alpha} in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles Blood, September 15, 2007; 110(6): 1895 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. F. de Godoy and S. Rattan Translocation of AT1- and AT2-Receptors by Higher Concentrations of Angiotensin II in the Smooth Muscle Cells of Rat Internal Anal Sphincter J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1088 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Okada, T. Inoue, T. Kikuta, Y. Watanabe, Y. Kanno, S. Ban, T. Sugaya, M. Horiuchi, and H. Suzuki A Possible Anti-Inflammatory Role of Angiotensin II Type 2 Receptor in Immune-Mediated Glomerulonephritis during Type 1 Receptor Blockade Am. J. Pathol., November 1, 2006; 169(5): 1577 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fujita, H. Okuda, O. Tsukamoto, Y. Asano, Y. L. A. Hirata, J. Kim, T. Miyatsuka, S. Takashima, T. Minamino, H. Tomoike, et al. Blockade of Angiotensin II Receptors Reduces the Expression of Receptors for Advanced Glycation End Products in Human Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): e138 - e139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takaoka, S. Uemura, H. Kawata, K.-i. Imagawa, Y. Takeda, K. Nakatani, N. Naya, M. Horii, S. Yamano, Y. Miyamoto, et al. Inflammatory Response to Acute Myocardial Infarction Augments Neointimal Hyperplasia After Vascular Injury in a Remote Artery Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 2083 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Sales, G. K. Sukhova, M. A. Lopez-Ilasaca, P. Libby, V. J. Dzau, and R. E. Pratt Angiotensin Type 2 Receptor Is Expressed in Murine Atherosclerotic Lesions and Modulates Lesion Evolution Circulation, November 22, 2005; 112(21): 3328 - 3336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iwai, R. Chen, Z. Li, T. Shiuchi, J. Suzuki, A. Ide, M. Tsuda, M. Okumura, L.-J. Min, M. Mogi, et al. Deletion of Angiotensin II Type 2 Receptor Exaggerated Atherosclerosis in Apolipoprotein E-Null Mice Circulation, September 13, 2005; 112(11): 1636 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Okumura, M. Iwai, A. Ide, M. Mogi, M. Ito, and M. Horiuchi Sex Difference in Vascular Injury and the Vasoprotective Effect of Valsartan Are Related to Differential AT2 Receptor Expression Hypertension, September 1, 2005; 46(3): 577 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Akishita, K. Nagai, H. Xi, W. Yu, N. Sudoh, T. Watanabe, M. Ohara-Imaizumi, S. Nagamatsu, K. Kozaki, M. Horiuchi, et al. Renin-Angiotensin System Modulates Oxidative Stress-Induced Endothelial Cell Apoptosis in Rats Hypertension, June 1, 2005; 45(6): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsuda, M. Iwai, J.-M. Li, H.-S. Li, L.-J. Min, A. Ide, M. Okumura, J. Suzuki, M. Mogi, H. Suzuki, et al. Inhibitory Effects of AT1 Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress Hypertension, April 1, 2005; 45(4): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Alfakih, R. A. Lawrance, A. Maqbool, K. Walters, S. G. Ball, A. J. Balmforth, and A. S. Hall The clinical significance of a common, functional, X-linked angiotensin II type 2-receptor gene polymorphism (-1332 G/A) in a cohort of 509 families with premature coronary artery disease Eur. Heart J., March 2, 2005; 26(6): 584 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhao, K. Egashira, K.-i. Hiasa, M. Ishibashi, S. Inoue, K. Ohtani, C. Tan, M. Shibuya, A. Takeshita, and K. Sunagawa Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2284 - 2289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, M. Iwai, L. Wu, H.-W. Liu, R. Chen, T. Jinno, J. Suzuki, M. Tsuda, X.-Y. Gao, M. Okumura, et al. Fluvastatin Enhances the Inhibitory Effects of a Selective AT1 Receptor Blocker, Valsartan, on Atherosclerosis Hypertension, November 1, 2004; 44(5): 758 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Johnstone, A. S. Perez, I. Nasser, R. Stewart, A. Vaidya, F. Al Ammary, B. Schmidt, G. Horowitz, J. Dolgoff, J. Hamilton, et al. Angiotensin Receptor Blockade With Candesartan Attenuates Atherosclerosis, Plaque Disruption, and Macrophage Accumulation Within the Plaque in a Rabbit Model Circulation, October 5, 2004; 110(14): 2060 - 2065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nickenig Should Angiotensin II Receptor Blockers and Statins Be Combined? Circulation, August 24, 2004; 110(8): 1013 - 1020. [Full Text] [PDF]
|
|
|
|
|
|
M. Iwai, H.-W. Liu, R. Chen, A. Ide, S. Okamoto, R. Hata, M. Sakanaka, T. Shiuchi, and M. Horiuchi Possible Inhibition of Focal Cerebral Ischemia by Angiotensin II Type 2 Receptor Stimulation Circulation, August 17, 2004; 110(7): 843 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Johren, A. Dendorfer, and P. Dominiak Cardiovascular and renal function of angiotensin II type-2 receptors Cardiovasc Res, June 1, 2004; 62(3): 460 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiuchi, M. Iwai, H.-S. Li, L. Wu, L.-J. Min, J.-M. Li, M. Okumura, T.-X. Cui, and M. Horiuchi Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice Hypertension, May 1, 2004; 43(5): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kawai, K. Ando, A. Tojo, T. Shimosawa, K. Takahashi, M. L. Onozato, M. Yamasaki, T. Ogita, T. Nakaoka, and T. Fujita Endogenous Adrenomedullin Protects Against Vascular Response to Injury in Mice Circulation, March 9, 2004; 109(9): 1147 - 1153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wu, M. Iwai, Z. Li, T. Shiuchi, L.-J. Min, T.-X. Cui, J.-M. Li, M. Okumura, C. Nahmias, and M. Horiuchi Regulation of Inhibitory Protein-{kappa}B and Monocyte Chemoattractant Protein-1 by Angiotensin II Type 2 Receptor-Activated Src Homology Protein Tyrosine Phosphatase-1 in Fetal Vascular Smooth Muscle Cells Mol. Endocrinol., March 1, 2004; 18(3): 666 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Isenovic, D. B. Jacobs, M. H. Kedees, Q. Sha, N. Milivojevic, K. Kawakami, G. Gick, and J. R. Sowers Angiotensin II Regulation of the Na+ Pump Involves the Phosphatidylinositol-3 Kinase and p42/44 Mitogen-Activated Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells Endocrinology, March 1, 2004; 145(3): 1151 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jinno, M. Iwai, Z. Li, J.-M. Li, H.-W. Liu, T.-X. Cui, H. Rakugi, T. Ogihara, and M. Horiuchi Calcium Channel Blocker Azelnidipine Enhances Vascular Protective Effects of AT1 Receptor Blocker Olmesartan Hypertension, February 1, 2004; 43(2): 263 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Korshunov and B. C. Berk Flow-Induced Vascular Remodeling in the Mouse: A Model for Carotid Intima-Media Thickening Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chen, M. Iwai, L. Wu, J. Suzuki, L.-J. Min, T. Shiuchi, T. Sugaya, H.-W. Liu, T.-X. Cui, and M. Horiuchi Important Role of Nitric Oxide in the Effect of Angiotensin-Converting Enzyme Inhibitor Imidapril on Vascular Injury Hypertension, October 1, 2003; 42(4): 542 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Lyon, R. E. Law, and W. A. Hsueh Minireview: Adiposity, Inflammation, and Atherogenesis Endocrinology, June 1, 2003; 144(6): 2195 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Horiuchi, T.-X. Cui, Z. Li, J.-M. Li, H. Nakagami, and M. Iwai Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation Circulation, January 7, 2003; 107(1): 106 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Li, M. Iwai, L. Wu, T. Shiuchi, T. Jinno, T.-X. Cui, and M. Horiuchi Role of AT2 receptor in the brain in regulation of blood pressure and water intake Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H116 - H121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Liu, M. Iwai, Y. Takeda-Matsubara, L. Wu, J.-M. Li, M. Okumura, T.-X. Cui, and M. Horiuchi Effect of Estrogen and AT1 Receptor Blocker on Neointima Formation Hypertension, October 1, 2002; 40(4): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xu, O. A. Carretero, Y.-H. Liu, E. G. Shesely, F. Yang, A. Kapke, and X.-P. Yang Role of AT2 Receptors in the Cardioprotective Effect of AT1 Antagonists in Mice Hypertension, September 1, 2002; 40(3): 244 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Suzuki, M. Iwai, H. Nakagami, L. Wu, R. Chen, T. Sugaya, M. Hamada, K. Hiwada, and M. Horiuchi Role of Angiotensin II-Regulated Apoptosis Through Distinct AT1 and AT2 Receptors in Neointimal Formation Circulation, August 13, 2002; 106(7): 847 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Egashira, Q. Zhao, C. Kataoka, K. Ohtani, M. Usui, I. F. Charo, K.-i. Nishida, S. Inoue, M. Katoh, T. Ichiki, et al. Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys Circ. Res., June 14, 2002; 90(11): 1167 - 1172. [Abstract] [Full Text] [PDF]
|
|